Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

752
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
752
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

812
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
812
Long-term Depression01:05

Long-term Depression

33.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.7K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Potentiation01:35

Long-term Potentiation

59.3K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
59.3K
Long-term Potentiation01:25

Long-term Potentiation

3.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Lithium Treatment and Sensory Processing Sensitivity in Bipolar Disorder Patients.

Neuropsychobiology·2026
Same author

Using multi-trait polygenic scores to predict lithium responsiveness in patients with bipolar disorder.

medRxiv : the preprint server for health sciences·2026
Same author

The pharmacological management of mixed mania/hypomania: where are we now?

Expert opinion on pharmacotherapy·2025
Same author

Pathway-Specific Polygenic Scores for Predicting Clinical Lithium Treatment Response in Patients With Bipolar Disorder.

Biological psychiatry global open science·2025
Same author

Essential information about chronobiology and chronotherapy for the optimal care of people with bipolar disorders: an international expert consensus.

medRxiv : the preprint server for health sciences·2025
Same author

The Mechanisms of Lithium Action: The Old and New Findings.

Pharmaceuticals (Basel, Switzerland)·2025
Same journal

The Role of Digital Health Technologies in Early Detection and Management of Alzheimer's Disease.

Current Alzheimer research·2026
Same journal

Quantifying Short-Term Functional Changes After Lecanemab Treatment in Early Alzheimer's Disease: An Exploratory 3-Month Follow-Up Case Report Using Eye Movement and Gait Analysis.

Current Alzheimer research·2026
Same journal

Corrigendum to: Advancing Alzheimer's Disease Diagnosis Using VGG19 and XGBoost: A Neuroimaging-Based Method.

Current Alzheimer research·2026
Same journal

Corrigendum to: Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease.

Current Alzheimer research·2026
Same journal

Apolipoprotein E Mimetics in Targeted Drug Delivery: Advances and Therapeutic Potential for Neurodegenerative and Cardiovascular Diseases.

Current Alzheimer research·2026
Same journal

Association of Polymorphisms in Genes Involved in Serotonergic Signaling with the Risk of Developing Alzheimer's Disease.

Current Alzheimer research·2026
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

84.0K

Effect of Lithium on Neurocognitive Functioning.

Janusz K Rybakowski1

  • 1Department of Adult Psychiatry, Poznan University of Medical Sciences, ul.Szpitalna 27/33, 60-572 Poznan, Poland. janusz.rybakowski@gmail.com.

Current Alzheimer Research
|April 19, 2016
PubMed
Summary
This summary is machine-generated.

Lithium treatment for bipolar disorder (BD) shows mixed effects on cognition. While some studies indicate cognitive benefits, others suggest a negative impact, possibly linked to mood stabilization and neuroprotection.

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.3K

Related Experiment Videos

Last Updated: Mar 22, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

84.0K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.3K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Lithium is a primary treatment for bipolar disorder (BD), managing manic and depressive episodes.
  • Lithium's effects on brain function are debated, with evidence for both neuroprotective and neurotoxic impacts.
  • Cognitive deficits are common in BD patients, varying with mood state and sometimes persisting during euthymia.

Purpose of the Study:

  • To investigate the complex relationship between lithium treatment and cognitive function in bipolar disorder.
  • To explore potential mechanisms underlying lithium's influence on cognition in BD patients.

Main Methods:

  • Review of experimental and clinical studies on lithium's effects on cognition in BD.
  • Analysis of meta-analyses comparing lithium-treated BD patients with untreated patients.
  • Examination of studies correlating lithium response with cognitive performance and dementia risk.

Main Results:

  • Lithium demonstrates dual effects on cognition; experimental studies often show benefits, while clinical meta-analyses suggest a moderate negative impact.
  • Cognitive function in excellent lithium responders mirrors that of healthy controls, indicating potential neuroprotective effects.
  • Lithium treatment may reduce dementia risk in BD patients.

Conclusions:

  • The impact of lithium on cognition in BD is multifaceted, influenced by its prophylactic efficacy and potential neuroprotective mechanisms.
  • Preventing affective recurrences, enhancing neural plasticity, and appropriate dosing may mitigate negative cognitive effects.
  • Further research is needed to fully elucidate lithium's cognitive profile in bipolar disorder.